Subject Index. chromatography step, 125-
|
|
- Marsha Shaw
- 6 years ago
- Views:
Transcription
1 A Alert limits, description, 70 Aluminum hydroxide based vaccine manufacture, start up and validation of sterile formulation and filling processes, Anion-exchange chromatography step for clinical-grade ciliary neurotrophic factor purification, reuse validation, B BebeFDC, production, 55 Biologies License Application, description, 171 Biologies regulations assay development and validation, case study of assay costs and times, change to approved application, 176 costs, 171 development, establishment license application elimination, lot release elimination, 177 methodology, process development, product comparability demonstration, use of pilot facilities, Biopharmaceutical agents, development process, 80 Biopharmaceutical manufacturing process validation concurrent validation, 5 current trends coordination of validation program and start up, 7 importance of communication, 8 prospective validation, 6-7 scope, 7-8,9t Subject Index 185 definitions, 2 Food and Drug Administration guidelines, 3 future trends, 8,10 history, 3-4 incentive, 1-2 requirements, 5 retrospective validation, 5 Biotechnology, process validation history, 1 C Cell culture process validation for monoclonal antibody production, See Continuously perfused cell culture process validation for monoclonal antibody production Center for Biologies Evaluation and Research, function, 4 Center for Drug Evaluation and Research, function, 4 Chinese hamster ovary cell line production of BebeFDC, 55 proven acceptable process control ranges for monoclonal antibody production, Chromatographic purification step used in recombinant factor DC manufacture, robustness testing, Chromatography, virus removal and inactivation validation, , Ciliary neurotrophic factor purification, reuse validation of anion-exchange chromatography step, Clean-in-place/steam-in-place technology, advances, 167 Clinical-grade ciliary neurotrophic factor purification, reuse validation of anionexchange chromatography step, Coagulation factor DC purification process, recombinant, See Recombinant coagulation factor DC
2 186 purification process validation for host cell DNA removal Concurrent validation description, 5 Container closure integrity, advances, 167 Continuously perfused cell culture process validation for monoclonal antibody production bioreactor validation, cell bank stability, 32, 33/, 40 definition, 41 experimental materials, antibody concentration, 31 immunoreactivity, 31 structure, cell banking, 31 clonality, 30 continuous perfusion process, 31 stability, 30 generation accumulation, 32, 34f process, requirements, 41 stability during production, 34, Coomassie-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis, role in proven acceptable process control ranges for monoclonal antibody production by recombinant Chinese hamster ovary cell cultures, Critical process parameters, Critical quality attributes, Development, role of biologies regulations on manufacturing processes for well-characterized products, DNA removal, recombinant coagulation factor DC purification process validation, Doubling times, calculation, 30 Drugs, process characterization for validation of recombinant protein fermentation, 1 F Factor DC manufacture, recombinant, robustness testing of chromatographic purification step, Factor IX purification process for host cell DNA removal, validation, Factorial approach, description, 70,72 Fermentation, recombinant protein, validation via process characterization, Filling process, See Sterile formulation and filling process start up and validation for parenteral aluminum hydroxide based vaccine manufacture predemonstration validation studies Filtration, virus removal and inactivation validation, , Food and Drug Administration, regulations of biologies, Fractional factorial designs, robustness testing of chromatographic purification step used in recombinant factor IX manufacture, G Guide to Inspection of Bulk Pharmaceutical Chemicals, description, 4 Guideline for the Inspection of Biotechnology Manufacturing Facilities, description, 4 Guideline on General Principles of Process Validation, description, 4 Guideline on Sterile Drug Products Produced by Aspectic Processing, description, 4
3 187 H Host cell DNA removal, recombinant coagulation factor DC purification process validation, N Neurotrophic factor purification, reuse validation of anion-exchange chromatography step, Inactivation, virus, Isoelectric focusing gel analysis, role in proven acceptable process control ranges for monoclonal antibody production by recombinant Chinese hamster ovary cell cultures, L Locally controlled environments, advances, 167 M Manufacturing of drugs and medical devices, process validation, 1 Manufacturing processes for wellcharacterized products, role of biologies regulations on development and validation, Maximum operating range, description, 70 Medical devices, process characterization for validation of recombinant protein fermentation, 1 Monoclonal antibody production continuously perfused cell culture process validation, proven acceptable process control ranges by recombinant Chinese hamster ovary cell cultures, Monoclonal antibody purification process, establishment of operating ranges, Monoclonal antibody validation, worstcase approach, O Operating range(s) in monoclonal antibody purification process establishment of ranges for critical input variables DNA content and clearance, 91 host cell protein content, protein A content, purity, results, 86, 87-90/ yield, purification process, 81 small-scale model development identification input variables, 82 output variables, 83 procedure, 82 quantification, use to establish operating ranges experimental design, 84 selection of ranges for input variables, Operating range validation goal, 69 worst-case approach, Parenteral aluminum hydroxide based vaccine manufacture, start up and validation of sterile formulation and filling processes, Parenteral formulations, importance of final sterile step, 144 Performance measures, role in proven acceptable process control ranges for monoclonal antibody production by recombinant Chinese hamster ovary cell cultures, 47,49, 50/
4 188 Process characterization for validation of recombinant protein fermentation bridging between small and large scales, critical process parameters and quality attributes, 19,23,4 experimental materials, 13 analytical methods, 14 culture conditions, fermentation kinetics, 14,16/ fermentation process, 14,15/ galactose feed rate and amount, 19,22/ glucose feed rate and amount, 17, 19, 20-21/ inoculum transfer criteria, 17,18/ window for harvest, 14, 17 Process validation components, 80 importance, 1 product quality acceptability, 44 standardization, 1 Product(s), role of biologies regulations on development and validation of manufacturing processes, Product titer, role in proven acceptable process control ranges for monoclonal antibody production by recombinant Chinese hamster ovary cell cultures, 47,48/ Production-level purification influencing factors, objective, 125 validation, Prospective validation description, 6-7 formal process validation, 6-7 performance qualification, 6 process characterization and optimization, 6 sterile processes, Protein(s), production problems, 114 Protein fermentation, validation via process characterization, Proven acceptable process control ranges for monoclonal antibody production by recombinant Chinese hamster ovary cell cultures Coomassie-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis, experimental materials, 45 measures of process performance and product quality, process variables and variable ranges, 45 study design, isoelectric focusing gel analysis, performance measure effects, 47,49, 50/ product titer effects, 47,48/ silver-stained sodium dodecyl sulfatepolyacrylamide gel electrophoresis, 51,52/ Purification establishment of operating ranges for monoclonal antibodies, reuse validation of anion-exchange chromatography for clinical grade ciliary neurotrophic factor, R Recombinant Chinese hamster ovary cell cultures, proven acceptable process control ranges for monoclonal antibody production, Recombinant coagulation factor DC purification process validation for host cell DNA removal concurrent validation of DNA evaluation ceramic HA peak pool, Q Sepharose load samples, Q Sepharose peak pool, 59 development, 56 laboratory-scale validation
5 189 radiolabeled DNA spike preparation, 60, 61/ results, 60-62, 63/ purification procedure, 57 robustness of DNA removal description, 62 drug substance DNA levels, immobilized metal affinity chromatography column robustness, 64-65, 66/ Q Sepharose column robustness, Recombinant factor IX manufacture, robustness testing of chromatographic purification step, Recombinant protein fermentation, validation via process characterization, Regeneron's recombinant human ciliary neurotrophic factor manufacturing process, reuse validation, Reinventing Government Initiative of 1995, description, 171 Removal, virus, Residual cellular DNA assaying problems, 56 role in process consistency and product purity, 56 Retrospective validation description, 5 Reuse validation of anion-exchange chromatography step for clinical-grade ciliary neurotrophic factor purification anthrone reactive material release, 140, 142/ column requirements, 125 consistency of pool material, 133,137, 138/ DNA clearance, 137, elution volume, 133, 136/ endotoxin clearance, 137, analytical methods DNA quantitation, 133 endotoxin quantitation, 133 protein determination, 132 sodium dodecyl sulfatepolyacrylamide gel electrophoresis, 132 bench-scale column system, 128 diethylaminoethyl-sepharose chromatography conditions elution, 131 final equilibration, 129 initial equilibration, 129 loading, 131 production run, 129, 130/ resin regeneration/sanitization, 131 wash step, 131 diethylaminoethyl-sepharose smallscale reuse study column specifications, 131,132r procedure, production process, 129 manufacturing process, percent yield, 133, 136/ reproducibility, 133, 135/ resin leachable release, 140,141/ retention volume, 133, 136/ small-scale profile vs. manufacturingscale profile, 133, 134/ 137r Robust process step, description, Robustness definition, 93, 36 establishment for complex unit operation, 94 Robustness testing of chromatographic purification step used in recombinant factor DC manufacture example choice of variables and ranges load conductivity and ph, 97-98, 111 load flow rate, 97 recombinant factor DC load mass, 97 untested variables, 99 data analysis, 100
6 190 fractional factorial design and execution, 100, 101* outputs, 99 process goals, 97 purification process, analytical methods, 96 chromatography, 96 variable manipulation, 96 future work, 111 principles of study design analysis of experimental results, 95 choice of variables, 95 definition of output, 94 experimental design, 95 identification of process goals, 94 selection of variable ranges, 95 results impurity levels, product composition, 109, 111 product recovery, Scaled-down model, Silver-stained sodium dodecyl sulfatepolyacrylamide gel electrophoresis, role in proven acceptable process control ranges for monoclonal antibody production by recombinant Chinese hamster ovary cell cultures, 51,52/ Start up, sterile formulation and filling process for parenteral aluminum hydroxide based vaccine manufacture, Sterile formulation and filling process start up and validation for parenteral aluminum hydroxide based vaccine manufacture approach steps, 152 variables affecting performance, ,155* background, current analyses, 146, 147* current trends, 164,167 demonstration phase, 162,164, / dilution and filling steps characterization phase, 158,162, 163/,* predemonstration validation studies, 158,162,163/,* formal validation phase, 162,164, / formulation step characterization phase, 153 demonstration phase, , / future trends, predemonstration validation studies aluminum and antigen concentration effect, 157 ph effect, procedure, 154 sterility, 157 processes automated ph titration system, 146, 149/ dilution, 146, 150 filling filling system, 152 mixing, formulation via aluminum hydroxide coprecipitation, 146,148/ Sterile products, process validation, 144 Sterile welding, advances, 167 Vaccine manufacture, parenteral aluminum hydroxide based, start up and validation of sterile formulation and filling processes, Validation continuously perfused cell culture process for monoclonal antibody production, definition, 12,80 process characterization of recombinant protein fermentation, 12-27
7 191 recombinant coagulation factor DC purification process for host cell DNA removal, requirements, reuse validation of anion-exchange chromatography step for clinicalgrade ciliary neurotrophic factor purification, role of biologies regulations on manufacturing processes for wellcharacterized products, sterile formulation and filling process for parenteral aluminum hydroxide based vaccine manufacture, virus removal and inactivation, worst-case approach to operating ranges, Viral contaminants, importance of removal, 114 Virus removal and inactivation validation chromatography procedure, 117 results, , design requirements, 116 equipment, 111 filtration procedure, 119 results, , goal, 114 inactivation procedure, 121 results, model viruses, unit operations, 117 W Well-characterized biologies designation, 10 role of biologies regulations on development and validation of manufacturing processes, Worst case, Worst-case approach to operating range validation advantages and disadvantages, 70 concept of operating ranges, definition, 70 experimental materials, 72, factorial approach, 70,72 isoelectric focusing gel quantitation, 74,78/ worst case and standard condition, 74, 77/ performance of cell culture process, 73-74,75/ protein A levels in purification process intermediates, 74,76/ purity of purification process intermediates, 74,76/ typical process flow for monoclonal antibody production, 70,71/ yield of purification process, 74,75/
BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE
The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate and/or remove potential viral contaminants. Experience and knowledge in selecting
More informationMONOCLONAL ANTIBODIES AND BIOSIMILARS production, naming, pharmacovigilance and other pharmaceutical quality aspects
1 MONOCLONAL ANTIBODIES AND BIOSIMILARS production, naming, pharmacovigilance and other pharmaceutical quality aspects Prof. dr. Jos G.W. Kosterink Department of Clinical Pharmacy and Pharmacology University
More informationJapanese Application Form: PMDA s Perspective on Manufacturing Process Description
Japanese Application Form: PMDA s Perspective on Manufacturing Process Description Reiko YANAGIHARA, Ph.D. Principal Reviewer Division of Pharmacopoeia and Standards for Drugs Office of Standards and Guideline
More informationIntroduction to Protein Purification
Introduction to Protein Purification 1 Day 1) Introduction to Protein Purification. Input for Purification Protocol Development - Guidelines for Protein Purification Day 2) Sample Preparation before Chromatography
More informationAdsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media. Dr. Robert Conway, Ph.D.
Adsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media Dr. Robert Conway, Ph.D. Depth Filter Cartridge Construction Zeta Plus Media Materials of Construction
More informationThe validation of biological Active Pharmaceutical
This article presents a procedure for the validation of biological API manufacturing processes. It details each step of the procedure for biological processes applications, and covers the regulatory requirements
More informationVirus Safety in Plasma- Derived Therapeutics: A Merck Perspective. IPFA Yogyakarta, March Louis Wong
Virus Safety in Plasma- Derived Therapeutics: A Merck Perspective IPFA Yogyakarta, March 2017 Louis Wong Associate director, Plasma Initiative, Asia-Pacific Content Regulatory Expectations for Plasma-Derived
More informationPRAXIS. A publication by Bioengineering AG
PRAXIS A publication by Bioengineering AG Portrait of Rentschler Biotechnologie GmbH, a globally active service company that supports its clients in the development, production, and registration of biopharmaceuticals.
More informationDuring biopharmaceutical
B i op r o c e s s Technical Development of an In-House, Process-Specific ELISA for Detecting HCP in a Therapeutic Antibody, Part 2 Edward Savino, Bing Hu, Jason Sellers, Andrea Sobjak, Nathan ajewski,
More informationDynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors
Contact Us: www.pall.com/contact Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors Dynamic High Capacity Mustang Q Membrane Units
More informationEuropean Medicines Agency
European Medicines Agency October 1997 CPMP/ICH/295/95 ICH Topic Q 5 A (R1) Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal
More informationGuideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials
14 September 2017 EMA/CHMP/BWP/534898/2008 rev. 1 Committee for Medicinal Products for Human Use (CHMP) Guideline on the requirements for quality documentation concerning biological investigational medicinal
More informationThe practical task of monoclonal IgG purification with CHT TM ceramic hydroxyapatite
The practical task of monoclonal IgG purification with CHT TM ceramic hydroxyapatite Pete Gagnon, Jie He, Paul Ng, Julia Zhen, Cheryl Aberin, Heather Mekosh 11th Annual Waterside Conference, Chicago, May
More informationquantitate host cell DNA with high sensitivity and throughput resdnaseq Host Cell DNA Quantitation Systems: CHO, E.
quantitate host cell DNA with high sensitivity and throughput resdnaseq Host Cell DNA Quantitation Systems: CHO, E. coli, Vero, NS0 Precision counts Integrated real-time qpcr systems for quantitation of
More informationFast Trak Services: a collaborative project to accelerate downstream biosimilar process development
GE Healthcare Fast Trak Services: a collaborative project to accelerate downstream biosimilar process development A case study Case study, 2924332 AA Fast Trak Services A collaborative project to accelerate
More informationPOROS HQ 50 and PI 50 resins in flow-through polish chromatography applications
APPLICATION NOTE POROS HQ 50 and PI 50 Resins POROS HQ 50 and PI 50 resins in flow-through polish chromatography applications Why and where to start? Introduction Anion exchange (AEX) chromatography products
More informationAn effective platform for purification of IgM monoclonal antibodies using Hydroxyapatite
An effective platform for purification of IgM monoclonal antibodies using Hydroxyapatite Frank Hensel, Patrys, GmbH Pete Gagnon, Validated Biosystems 5th International Conference on Hydroxyapatite and
More informationSimplicity is the key Continuous purification of monoclonal antibodies
Simplicity is the key Continuous purification of monoclonal antibodies L. Landric-Burtin Head of Downstream Processing Development, France Integrated Continuous Biomanufacturing Conference, Barcelona,
More informationManufacturing Integrated Biologics Manufacturing
Manufacturing Integrated Biologics Manufacturing Integrated Biologics Manufacturing Abzena provides customer focused process development and manufacturing services for cgmp and non-gmp production of recombinant
More informationMabSelect PrismA. gelifesciences.com/bioprocess
is a next-generation Protein A chromatography resin that offers significantly enhanced alkaline stability and binding capacity for improved process economy in monoclonal antibody (mab) processing. The
More informationKinetics Review. Tonight at 7 PM Phys 204 We will do two problems on the board (additional ones than in the problem sets)
Quiz 1 Kinetics Review Tonight at 7 PM Phys 204 We will do two problems on the board (additional ones than in the problem sets) I will post the problems with solutions on Toolkit for those that can t make
More informationPurification of Recombinant Proteins on Nuvia TM cprime TM Hydrophobic Cation Exchange Media: A Simple Approach to Method Development
Purification of Recombinant Proteins on Nuvia TM cprime TM Hydrophobic Cation Exchange Media: A Simple Approach to Method Development Xuemei M. He, Sherif Hanala, and Mark Snyder, Bio-Rad Laboratories,
More informationPurification of alpha-1 antitrypsin using an antibody based affinity chromatography medium
Purification of alpha-1 antitrypsin using an antibody based affinity chromatography medium Ulrika Meyer a, Hanna Wlad a, Sven Blokland b, Frank J.M. Detmers b and Henrik Ihre a a GE Healthcare Bio-Sciences
More informationFast decisions instead of delays Quality Control through outstanding design
Fast decisions instead of delays Quality Control through outstanding design We are CustomBiotech from Roche In your operations, behind your decisions, powering your products You are driving a paradigm
More informationImproving Bioprocessing Productivity Through the Application of Single-Use Protein A Columns
Improving Bioprocessing Productivity Through the Application of Single-Use Protein A Columns By K. John Morrow, Jr. Ph.D. In the last two decades, the bioprocessing industry has confronted the demands
More informationAffinity Chromatography Media. Technical Data Sheet. Fine Chemicals Sales Department
Affinity Chromatography Media Cellufine Sulfate Technical Data Sheet Fine Chemicals Sales Department 2-1, Otemachi 2-Chome Chiyoda-ku, Tokyo 100-8105 JAPAN Phone +81-3-3243-6150 Fax +81-3-3243-6219 e-mail:
More informationHistorical, Current, and Future Trends for Validating Biological Processes
Chapter 1 Historical, Current, and Future Trends for Validating Biological Processes R. Andrew Ramelmeier 1, Brian D. Kelley 2, and Christi Van Horn 3 1 Merck Research Laboratories, West Point, PA, 19486
More informationBiologics. Biologics. The Centre for Process Innovation. From innovation to commercialisation
Biologics Biologics The Centre for Process Innovation From innovation to commercialisation The Centre for Process Innovation From innovation to commercialisation The High Value Manufacturing Catapult is
More informationPURIFICATION OF MONOCLONAL ANTIBODIES UTILIZING A NOVEL CHROMATOGRAPHY RESIN OPERATED IN FLOW-THROUGH MODE
MQP-BC-DSA-8506 PURIFICATION OF MONOCLONAL ANTIBODIES UTILIZING A NOVEL CHROMATOGRAPHY RESIN OPERATED IN FLOW-THROUGH MODE A Major Qualifying Project Report Submitted to the Faculty of the WORCESTER POLYTECHNIC
More informationEuropean Regulatory Experiences and Expectations of HCP Analysis and Control
HCP Strategy Forum, Washington DC, January 26, 2015 www.pei.de European Regulatory Experiences and Expectations of HCP Analysis and Control Blood Products: Dr. Erika Friedl, PEI (DE) Discalimer: The views
More informationCase Studies of POROS Chromatography for Use in Vaccine and Large Biomolecule Purification
Case Studies of POROS Chromatography for Use in Vaccine and Large Biomolecule Purification Rev 1 (Life Tech template) Shelly Cote Parra April 2011 Topics Introduction to POROS Chromatography Products Principles,
More informationOutsourcing and Partnering for Commercial Grade Manufacturing Frank Tufaro, Ph.D.
Outsourcing and Partnering for Commercial Grade Manufacturing Frank Tufaro, Ph.D. Should You Partner Manufacturing? $$$ versus Control 2 Ph. 1 Registration Trials Commercial Launch CMO CMO or Partner CMO
More informationA Unique LC-MS Assay for Host Cell Proteins(HCPs) ) in Biologics
A Unique LC-MS Assay for Host Cell Proteins(HCPs) ) in Biologics Catalin Doneanu,, Ph.D. Biopharmaceutical Sciences, Waters September 16, 2009 Mass Spec 2009 2009 Waters Corporation Host Cell Proteins
More informationProtein Techniques 1 APPENDIX TO CHAPTER 5
Protein Techniques 1 APPENDIX T CHAPTER 5 Dialysis and Ultrafiltration If a solution of protein is separated from a bathing solution by a semipermeable membrane, small molecules and ions can pass through
More informationProcess validation is defined in the
Process Validation How Much to Do and When to Do It Anurag S. Rathore, Joseph F. Noferi, Edward R. Arling, Gail Sofer, Peter Watler, and Rhona O Leary The trick to process validation, these industry experts
More informationGala s Gene Product Expression (GPEx ) Platform
Gala Biotech A Company with Gene Insertion and Manufacturing Technologies for the Next Generation of Gene Expression and Biologics Production Gala s Gene Product Expression (GPEx ) Platform Rapid creation
More informationARBRE-P4EU Consensus Protein Quality Guidelines for Biophysical and Biochemical Studies Minimal information to provide
ARBRE-P4EU Consensus Protein Quality Guidelines for Biophysical and Biochemical Studies Minimal information to provide Protein name and full primary structure, by providing a NCBI (or UniProt) accession
More informationEuropean Guideline for Virus Safety Evaluation of Clinical Trial Material
Plasma Product Biotechnology Meeting, May 8 12, 2007 European Guideline for Virus Safety Evaluation of Clinical Trial Material Dr. Hannelore Willkommen Vice President Regulatory Affairs, NewLab Bioquality
More informationFiltration of Cell Culture Growth Media and Process Buffers
Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration of Cell Culture Growth Media and Process Buffers Introduction Media feeds and process buffers are two universal additives
More informationDeveloping an Appropriate Design Space Strategy to Mitigate Variability in Downstream Processing Operations
1 Developing an Appropriate Design Space Strategy to Mitigate Variability in Downstream Processing Operations Justin McCue Biogen Idec Corporation September, 2010 1 2 Overview Chromatography column scale
More informationBio-Monolith Protein G Column - More Options for mab Titer Determination
Bio-Monolith Protein G Column - More Options for mab Titer Determination Application Note Biologics and Biosimilars Author Phu T. Duong Agilent Technologies, Inc. Introduction In recent years, monoclonal
More informationProduct Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex
Product Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex Brand Name : BOTO GENIE 1. Introduction : BOTO GENIE (Botulinum Toxin Type A for Injection Ph.Eur)
More informationThe Role of Mass Spectrometry for Developing Biotherapeutics: Regulatory Perspectives
The Role of Mass Spectrometry for Developing Biotherapeutics: Regulatory Perspectives Jun Park, Ph.D. Division of Monoclonal Antibodies Office of Biotechnology Products CDER/FDA CASSS, Applications of
More informationThe World Leader in SPR Technology. Jimmy Page, PhD, Biacore, Inc.
The World Leader in SPR Technology Jimmy Page, PhD, Biacore, Inc. Objectives of Biacore Experiments Yes/No Data» Is there binding?» Ligand Fishing Concentration Analysis: How MUCH? Active Concentration
More informationCultivation of sensitive cell lines - Improving bioreactor performance by dynamic membrane aeration
Cultivation of sensitive cell lines - Improving bioreactor performance by dynamic membrane aeration Björn Frahm, Helmut Brod Bioprocessing Summit Optimizing Cell Culture Technology, Boston, 2010-08-24
More informationDevelopment of a MEP HyperCel IgG purification process for a Commercial Polyclonal Antibody Product
North America Europe Australasia LSE : PTI.L NASDAQ : PTIL Development of a MEP HyperCel IgG purification process for a Commercial Polyclonal Antibody Product Richard Francis Process Development Director,
More informationNPTEL VIDEO COURSE PROTEOMICS PROF. SANJEEVA SRIVASTAVA
LECTURE-06 PROTEIN PURIFICATION AND PEPTIDE ISOLATION USING CHROMATOGRAPHY TRANSCRIPT Welcome to the proteomics course. Today, we will talk about protein purification and peptide isolation using chromatography
More informationTom Sulpizio and Jeff Taniguchi, Advanced Minerals Corporation A Member of Imerys 130 Castilian Way, Santa Barbara, CA 93117
ADVANCES IN DISPOSABLE DIATOMITE FILTER AID SYSTEMS FOR CGMP BIOSEPARATIONS Session Pretreatment in Bioseparations AFSS Annual Meeting Valley Forge, PA May 20, 2008 ABSTRACT Tom Sulpizio and Jeff Taniguchi,
More informationThe Use of Disposable Technologies in Antibody Manufacturing Processes
The Use of Disposable Technologies in Antibody Manufacturing Processes Tim Matthews and Brad Wolk Process Development Engineering Genentech, Inc. South San Francisco, CA Outline Rationale for using disposable
More informationMonoclonal Antibody Purification and Technology for Improving Virus Clearance
Monoclonal Antibody Purification and Technology for Improving Virus Clearance BioProcessing Network Annual Conference Brisbane, September 2009 Germano Coppola Technology Transfer Manager CSL Limited Outline
More informationDeveloping Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus
Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus Robert Birdsall, Thomas Wheat, and Weibin Chen Waters Corporation,
More informationOctober 10, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852
October 10, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA 2017 D 2802: Chemistry, Manufacturing, and Controls
More informationUse of Fluidised bed chromatography for plasma fractionation. Karl McCann*, John Wu, Peter Gomme & Joseph Bertolini
Use of Fluidised bed chromatography for plasma fractionation Karl McCann*, John Wu, Peter Gomme & Joseph Bertolini Plasma Fractionation Industry Mature with well established processes Revenue growth -
More informationConsiderations During Development of a Protein A-Based Antibody Purification Process
Considerations During Development of a Protein A-Based Antibody Purification Process Scale-up changes in an antibody purification process can increase final product purity, make the process more robust,
More informationAnnex 4. Guidelines on the quality, safety and efficacy of biotherapeutic protein products prepared by recombinant DNA technology
Guidelines on the quality, safety and efficacy of biotherapeutic protein products prepared by recombinant DNA technology Replacement of Annex 3 of WHO Technical Report Series, No. 814 Introduction 177
More informationRhinophase -AB, Zirconia-based Monoclonal Antibody Purification System
Rhinophase -AB, Zirconia-based Monoclonal Antibody Purification System Welcome to the sixth issue of ZirChrom's electronic newsletter. This newsletter introduces a biocompatible stationary phase useful
More informationFRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME INTEGRATED PRODUCTION PLATFORMS GMP-COMPLIANT PRODUCTION OF BIOPHARMACEUTICALS
FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME INTEGRATED PRODUCTION PLATFORMS GMP-COMPLIANT PRODUCTION OF BIOPHARMACEUTICALS Close-up of large scale UF/DF control unit conditions and
More informationU.S. Pharmacopeia National Formulary. USP 39 Published General Chapter <1132> Residual Host Cell Protein Measurement in Biopharmaceuticals
2016 U.S. Pharmacopeia National Formulary USP 39 NF 34 USP 39 Published General Chapter Residual Host Cell Protein Measurement in Biopharmaceuticals The official version can be found in the USP
More informationA Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody.
A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody. Jeremy M Tong (presenting), Mark S Kettel, Edward M Perry, David J Pain, David M Valentine,
More informationThe Future is NOW for Continuous Manufacturing Part 3 Multi Column Continuous (MCC) Chromatography
The Future is NOW for Continuous Manufacturing Part 3 Multi Column Continuous (MCC) Chromatography Dr. Kathleen Mihlbachler Global Director of Separation Development LEWA Process Technologies 15 01 2015
More informationPresented at the ECI Conference on Integrated Continuous Biomanufacturing Castelldefels, Spain, October 21, 2013
Continuous Antibody Capture with Protein A Countercurrent Tangential Chromatography: A New Column-Free Approach for Antibody Purification Andrew L. Zydney Department Head and Walter L. Robb Family Chair
More informationCGMP for Phase 1 INDs
CGMP for Phase 1 INDs Laurie P. Norwood Deputy Director Division of Manufacturing and Product Quality Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research 1 Overview
More informationGE Healthcare. Purification of monoclonal antibodies using modern chromatography media and membranes
GE Healthcare Purification of monoclonal antibodies using modern chromatography media and membranes Purification of monoclonal antibodies using modern chromatography media and membranes The use of monoclonal
More information0E.03. profos AG. creative bioscience solutions. product information. creative bioscience solutions
0E.03 profos AG profos AG is a reliable and steadily growing biotechnology company. The combination of science, creativity and versatility under the paradigm of efficiency are our philosophy. Our products
More informationDriving Value through Innovation in Biotech Manufacturing. Agenda
Driving Value through Innovation in Biotech Manufacturing Jorg Thommes, PhD Senior Vice President Operations Technology and Innovation Biogen 7 October 2015 Agenda Biopharma Legacy, Trends, & Challenges
More informationTo date, the majority of
B i o P r o c e s s TECHNICAL Evaluating Adsorptive Filtration As a Unit Operation for Virus Removal Mario Metzger, Anja Gerster, Marcus Peiker, Sabine Faust, Alexander Faude, Sybille Ebert, Sophie Winterfeld,
More informationmab Titer Analysis with the Agilent Bio-Monolith Protein A Column
mab Titer Analysis with the Agilent Bio-Monolith Protein A Column Application Note Biopharmaceuticals and Biosimilars Authors Emmie Dumont, Isabel Vandenheede, Pat Sandra, and Koen Sandra Research Institute
More informationProSep Ultra Plus Chromatography Media
Data Sheet Data Sheet ProSep Ultra Plus Chromatography Media The highest dynamic binding capacity protein A affinity chromatography media, designed for cost effective, large-scale purification of today
More informationLifetime stability of size exclusion chromatography columns for protein aggregate analysis
APPLICATION NOTE 72362 Lifetime stability of size exclusion chromatography columns for protein aggregate analysis Authors Amy Farrell 1, Craig Jakes 1, Alexander Ley 2, Mauro De Pra 2, Frank Steiner 2,
More informationGuideline on requirements for the production and control of immunological veterinary medicinal products
14 June 2012 EMA/CVMP/IWP/206555/2010 Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on requirements for the production and control of immunological veterinary Draft agreed by Immunologicals
More information1. Connect the column to the chromatography system, syringe or pump.
BabyBio TREN INSTRUCTIONS IN 45 655 030 The ready-to-use BabyBio TREN columns are prepacked with WorkBeads 40 TREN resin and are available in two column sizes, 1 ml and 5 ml. WorkBeads 40 TREN resin for
More informationLabChip GXII: Antibody Analysis
WHITE PAPER LabChip GXII: Antibody Analysis Antibody Analysis using microfluidic technology in high throughput Quality by Design Experiments Abstract Current initiatives in Process Analytical Technology
More informationApplication of Single-Use Equipment for Buffer Storage and Distribution in Medium Size mab Production Facility
Reprinted from PHARMACEUTICAL ENGINEERING THE OFFICIAL TECHNICAL MAGAZINE OF ISPE JANUARY/FEBRUARY 2014, VOL 34, NO 1 Copyright ISPE 2014 www.pharmaceuticalengineering.org facilities and equipment Application
More informationDisposable devices for unit
D I S P O S A B L E S DOWNSTREAM Disposable Membrane Chromatography Performance Analysis and Economic Cost Model by Jeff Mora, Andrew Sinclair, Noushin Delmdahl, and Uwe Gottschalk Disposable devices for
More information3. Close the bottom end of the column and apply the packing device on top. Pump water through the upper adaptor to remove air.
INSTRUCTIONS FOR USE WorkBeads Protein A Product name Pack size Article number WorkBeads Protein A Bulk Media 1.5 ml 40605001 Bulk Media 5 ml 40605002 Bulk Media 10 ml 40605003 Bulk Media 100 ml 40605004
More informationMagSi Beads. Magnetic Silica Beads for Life Science and Biotechnology study
MagSi Beads Magnetic Silica Beads for Life Science and Biotechnology study MagnaMedics Diagnostics B.V. / Rev. 9.2 / 2012 Wide range of products for numerous applications MagnaMedics separation solutions
More informationApplication note. Purification of PEGlyated proteins with Contichrom
Application note Purification of PEGlyated proteins with Contichrom ChromaCon AG // Purification of PEGylated proteins with Contichrom // www.chromacon.ch // ver. May 2013 1 Summary The purification of
More informationCapillary Electrophoresis Compendial Applications
Capillary Electrophoresis Compendial Applications Anita Szajek, Ph.D. Principal Scientific Liaison, Biologics & Biotechnology 14 th Symposium on the Practical Applications for the Analysis of Proteins,
More informationOpportunities for Accelerating Cell Line Development and Beyond
Opportunities for Accelerating Cell Line Development and Beyond European CM&C Strategy Forum May 24, 2017 Christopher Frye, Ph.D. Research Advisor & Group Leader Bioprocess R&D Presentation Outline CM&C
More informationAdvanced Microbial Protein Expression
Advanced Microbial Protein Expression Partners for Life Advancing tomorrow s medicines w A Biologics and Vaccines CDMO partner for your complete clinical journey Good science, experience and a quality
More informationStability of Biological Products
Stability of Biological Products Dr Jurgen Lindner Principal, BioPharma Consulting & Executive Secretary, APIMAA Biological Products Functional Proteins or Polypeptides (mab s, enzymes & inhibitors, growth
More informationINSECT CELL/BACULOVIRUS PRODUCTION
INSECT CELL/BACULOVIRUS PRODUCTION PEF # GENE NAME TRANSFER VECTOR BEVS MOLECULAR WEIGHT 2015-XXXX XXXX pbac1 flashbacultra TM 36.0 kda EXPRESSION METHOD OVERVIEW: Insect cells Spodoptera frugiperda (Sf9)
More informationApplications involving the ViroCyt Virus Counter in the production of various recombinant proteins
Applications involving the ViroCyt Virus Counter in the production of various recombinant proteins Chris Kemp Kempbio, Inc. Frederick, MD USA chris.kemp@kempbioinc.com Presentation Summary Kempbio, Inc.
More informationDoc. No. Protocol to Monitor the Stability of the Adenovirus RD Reference Material Page: 1 of 14. Name/ Date
SOP Name/ Date Barry Sugarman Signature on file Name/ Date Beth Hutchins Signature on file Title: Adenovirus Reference Material : 1 of 14 Name/ Date Jonna Ellsworth Signature on file Name/ Date 1.0 PURPOSE
More informationHigh Throughput Screening Technologies for developing purification processes of proteins. Michel Eppink, Synthon BV, Nijmegen
High Throughput Screening Technologies for developing purification processes of proteins Michel Eppink, Synthon BV, Nijmegen Introduction Overview From small to large processes New protein purification
More informationPurification of (recombinant) proteins. Pekka Lappalainen, Institute of Biotechnology, University of Helsinki
Purification of (recombinant) proteins Pekka Lappalainen, Institute of Biotechnology, University of Helsinki Physical properties of proteins that can be applied for purification -size -charge (isoelectric
More informationApplication Note USD Purification of Mouse IgM from Cell Culture Supernatant by Cation Exchange Chromatography on CM Ceramic HyperD F Sorbent
Application Note USD 241 Purification of Mouse IgM from Cell Culture Supernatant by Cation Exchange Chromatography on CM Ceramic HyperD F Sorbent What this Study Demonstrates T h i s s t u d y o n C a
More informationGuideline for the Quality, Safety, and Efficacy Assurance of Follow-on Biologics
Provisional Translation (as of April 19, 2013) PFSB/ELD Notification No. 0304007 March 4, 2009 To: Prefectural Health Department (Bureau) From: Evaluation and Licensing Division, Pharmaceutical and Food
More informationThe Development of a Bio-inspired, Chemically Defined Media Supplement for Cell Culture
The Development of a Bio-inspired, Chemically Defined Media Supplement for Cell Culture Justin Oliver*, Kirti Chaturvedi*, Damon Barbacci, Cindy Hunt, and Elizabeth Dodson BD Biosciences Advanced Bioprocessing,
More information1. Bloomsbury BBSRC Centre for Structural Biology, Birkbeck College and University College London.
Purification/Polishing of His-tagged proteins - Application of Centrifugal Vivapure Ion-exchange Membrane Devices to the Purification/Polishing of Histagged Background Multi-milligram quantities of highly
More informationPurification of Lactate Dehydrogenase
Dominican University of California Dominican Scholar Scholarly & Creative Works Conference 2018 Scholarly and Creative Works Conference 2016 Apr 15th, 1:30 PM - 2:00 PM Purification of Lactate Dehydrogenase
More informationPharmaceutical Biotechnology
Pharmaceutical Biotechnology Debbie S. Retnoningrum; Catur Riani; Tri Suciati; Heni Rachmawati; Ana Indrayati School of Pharmacy, ITB Introduction 1 REFERENCES Glick, BR and JJ Pasternak, 2003, Molecular
More informationProtein G HP SpinTrap / Ab Spin Trap
GE Healthcare Life Sciences Protein G HP SpinTrap / Ab Spin Trap Product booklet Codes: 28-9031-34 28-4083-47 Page finder 1. Legal 3 2. Handling 4 2.1. Safety warnings and precautions 4 2.2. Storage 4
More informationLecture 8: Affinity Chromatography-III
Lecture 8: Affinity Chromatography-III Key words: Chromatography; Affinity chromatography; Protein Purification During this lecture, we shall be studying few more examples of affinity chromatography. The
More informationTECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12
INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE TECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12 ANNEX Draft
More informationWednesday, August 17, Mini-Review (2016) in Applied Microbiology and Biotechnology
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production Wednesday, Mini-Review () in Applied Microbiology
More informationCell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products
Cell Line Characterization and Product Testing for CHO-Derived Biopharmaceutical Products Founded in 96, Eurofins Lancaster Laboratories is a global leader in comprehensive laboratory services enabling
More informationHot Topics in Drug Product Process Validation: A Reviewer s Perspective
Hot Topics in Drug Product Process Validation: A Reviewer s Perspective Colleen Thomas, Ph.D. Quality Assessment Lead (Acting) FDA/CDER/OPQ/OPF Division of Microbiology Assessment CASSS CMC Strategy Forum
More informationPurification: Step 1. Lecture 11 Protein and Peptide Chemistry. Cells: Break them open! Crude Extract
Purification: Step 1 Lecture 11 Protein and Peptide Chemistry Cells: Break them open! Crude Extract Total contents of cell Margaret A. Daugherty Fall 2003 Big Problem: Crude extract is not the natural
More information